Cwm, LLC Agios Pharmaceuticals, Inc. Transaction History
Cwm, LLC
- $28.4 Billion
- Q2 2025
A detailed history of Cwm, LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Cwm, LLC holds 5,286 shares of AGIO stock, worth $196,639. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,286
Previous 1,659
218.63%
Holding current value
$196,639
Previous $49,000
259.18%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding AGIO
# of Institutions
235Shares Held
59.9MCall Options Held
323KPut Options Held
367K-
Farallon Capital Management LLC San Francisco, CA5.7MShares$212 Million0.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$208 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$181 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$131 Million2.39% of portfolio
-
State Street Corp Boston, MA2.45MShares$91.1 Million0.0% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.04B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...